Marc Belsky
Overview
Marc Belsky received $2M in total compensation, including $375K in salary, at Kezar Life Sciences in 2019. Marc Belsky also received an average of $1M at Five Prime Therapeutics from 2014 to 2018.
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Kezar Life SciencesChief Financial Officer
Five Prime TherapeuticsFormer Senior Vice President and Chief Financial Officer
Five Prime TherapeuticsSenior Vice President and Chief Financial Officer
Five Prime TherapeuticsSenior Vice President and Chief Financial Officer
Five Prime TherapeuticsSenior Vice President and Chief Financial Officer
Five Prime TherapeuticsSenior Vice President and Chief Financial Officer
Source: SEC filings on April 29, 2020, April 29, 2019, March 30, 2018, and March 31, 2017.
Related executives
We found 14 more executives who work or worked at Kezar Life Sciences and Five Prime Therapeutics.
John Fowler
Kezar Life Sciences
Chief Executive Officer
Noreen Henig
Kezar Life Sciences
Chief Medical Officer
Christopher Kirk
Kezar Life Sciences
Chief Scientific Officer
Aron Knickerbocker
Five Prime Therapeutics
Chief Executive Officer
Niti Goel
Kezar Life Sciences
Chief Medical Officer
Helen Collins
Five Prime Therapeutics
Chief Medical Officer
Francis Sarena
Five Prime Therapeutics
Secretary
William Ringo
Five Prime Therapeutics